Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vivimed Labs Ltd. Capital/Financing Update 2021

Sep 7, 2021

61575_rns_2021-09-07_909de99c-464a-4855-9b2f-45bd80223ecb.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Date: 06.09.2021

BSE - Code : 532660 Mumbai - 400 051

BSE Limited National Stock Exchange of India Ltd. P.J.Towers, Dalal Street, Exchange Plaza,Plot no. C/1, G Block, Mumbai — 400001 Bandra-Kurla Complex, Bandra (E) NSE- Symbol: VIVIMEDLAB

Sub: Outcome of the Meeting of the Board of Directors of the Company — reg.

With respect to offer or invitation made earlier (Resolutions passed vide postal ballot notice dated 14.11.2019) to issue upto (a) 1,00,00,000 (One Crore only) warrants exercisable as per its terms and conditions ("Non - Promoter Warrants") and (b) 1,50,00,000 (One hundred Fifty Lakhs only) warrants exercisable as per its terms and conditions ("Promoter Warrants") on a preferential basis have been withdrawn by the company. The proposed allottees have withdrawn their consent to apply for warrants due to cash flow problems arised because of COVID-19. Hence the Board of Directors of the Company has approved the withdrawal of consent by all the Proposed allottees.

BSE - Code : 532660 Mumbai - 400 051
NSE- Symbol: VIVIMEDLAB
Dear Sir/Madam
Sub: Outcome of the Meeting of the Board of Directors of the Company — reg.
The Board of Directors of the Company at its meeting held on September 06, 2021 inter alia, have
approved / resolved/ taken note of the following:
1. Withdrawal of earlier Proposed Preferential issue of warrants
withdrawn
2.
To
With respect to offer or invitation made earlier (Resolutions passed vide postal ballot notice dated
14.11.2019) to issue upto (a) 1,00,00,000 (One Crore only)
conditions ("Non - Promoter Warrants") and (b) 1,50,00,000 (One hundred Fifty Lakhs only) warrants
exercisable as per its terms and conditions ("Promoter Warrants") on a preferential basis have been
proposed
The
company.
by the
warrants due to cash flow problems arised because of COVID-19. Hence the Board of Directors of the
Company has approved the withdrawal of consent by all the Proposed allottees.
Proposal for Preferential Issue of Warrants:
issue upto 4,25,00,000 (Four crores Twenty five lakhs only)
promoters, subject to the necessary approvals and the warrants will be convertible into equivalent
number of equity shares of Rs.2/- each and will be issued at a price Rs.25/-
price specified in SEBI (Issue of Capital and Disclosure Requirements) (ICDR Regulations") and on
have withdrawn
allottees
warrants exercisable as per its terms and
apply for
consent to
their
Warrants to Promoters / Non
or not lower than the
such further terms and conditions specified in the applicable laws/ guidelines/ regulations etc
Group Proposed Allottees:
Promoter/Promoter
No of convertible
SI. No Name of the Proposed Allottees Category warrants to be allotted
Tanmayi Varalwar Resident Indian 25,00,000
_ Sanketh Varalwar Non Resident Indian 50,00,000
2
3
Manas Varalwar Resident Indian 25,00,000
4 Madhavi Varalwar Resident Indian 25,00.000
Total 1,25,00,000
Non-Promoter(s)/Non-Promoter Group Proposed Allottees:
Sl. No Name of the Proposed Allottees Category No of convertible
warrants to be allotted
1,00,00,000
] Yuga Infratech Private Limited An Indian Private
Limited Company 1,00,00,000
2 Procon Power Tech Private Limited An Indian Private
Limited Company

Promoter/Promoter Group Proposed Allottees:

Non-Promoter(s)/Non-Promoter Group Proposed Allottees:

1. Withdrawal of earlier Proposed Preferential issue of warrants
withdrawn With respect to offer or invitation made earlier (Resolutions passed vide postal ballot notice dated
14.11.2019) to issue upto (a) 1,00,00,000 (One Crore only)
conditions ("Non - Promoter Warrants") and (b) 1,50,00,000 (One hundred Fifty Lakhs only) warrants
exercisable as per its terms and conditions ("Promoter Warrants") on a preferential basis have been
proposed
The
company.
by the
warrants due to cash flow problems arised because of COVID-19. Hence the Board of Directors of the
Company has approved the withdrawal of consent by all the Proposed allottees.
have withdrawn
allottees
warrants exercisable as per its terms and
apply for
consent to
their
2. Proposal for Preferential Issue of Warrants:
Warrants to Promoters / Non
issue upto 4,25,00,000 (Four crores Twenty five lakhs only)
To
promoters, subject to the necessary approvals and the warrants will be convertible into equivalent
or not lower than the
number of equity shares of Rs.2/- each and will be issued at a price Rs.25/-
price specified in SEBI (Issue of Capital and Disclosure Requirements) (ICDR Regulations") and on
such further terms and conditions specified in the applicable laws/ guidelines/ regulations etc
Group Proposed Allottees:
Promoter/Promoter
Category No of convertible
SI. No Name of the Proposed Allottees warrants to be allotted
_ Tanmayi Varalwar Resident Indian 25,00,000
2 Sanketh Varalwar Non Resident Indian 50,00,000
3 Manas Varalwar Resident Indian 25,00,000
Resident Indian 25,00.000
4 Madhavi Varalwar Total 1,25,00,000
Non-Promoter(s)/Non-Promoter Group Proposed Allottees: Category No of convertible
Sl. No Name of the Proposed Allottees warrants to be allotted
An Indian Private 1,00,00,000
] Yuga Infratech Private Limited Limited Company
An Indian Private 1,00,00,000
2 Procon Power Tech Private Limited Limited Company
An Indian Proprietary 1,00,00,000
3 Enviro Green Technologies Concern
Total
3,00,00,000

Vivimed Labs Limited.

CIN: L02411KA1988PLC009465 (j Registered Office: #78/A, Kolhar Industrial Area, Bidar, Karnataka - 585 403, India. T +91 (0} 8482-232045, F +91 (0) 8482-232436 Email: contactlavivimedlabs.com | www.vivimedlabs.com

'\, Corporate Office: Worth End, Road No. 2 Sanjara Hills, Hyderabad, » Telangana - 500 034, India. 6 GSTIN: 36AAACV6060A1ZQ T +91(0) 40-6608-6608, F +91(0) 40-6608-6699

    1. Approved an enabling resolution for raising of funds through issue of equity shares through QIP/GDR/ADR/FCCB/Other Securities up to an amount of Rs.250 crores subject to approval of the Shareholders/ Regulatory and/or Statutory Authorities as applicable.
    1. Meeting of Shareholders

The Board also approved that a meeting of the shareholders' of the Company shall be conducted vide postal ballot for seeking approval of aforementioned matters.

You are requested to take note of the above. Yours faithfully

For Vivimed Labs Limited Gyageroort andhar Company Secretary